Therapeutic termination of second trimester pregnancy with vaginal misoprostol
Objective : To evaluate the efficacy of vaginal misoprostol in therapeutic termination of second trimester pregnancy with a live fetus. Design : Prospective descriptive study. Setting : Maharaj Nakorn Chiang Mai Hospital, Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai Unive...
Saved in:
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
2014
|
Online Access: | http://www.scopus.com/inward/record.url?eid=2-s2.0-0034851762&partnerID=40&md5=1fa041b5b747065de8db3aac24c42bed http://www.ncbi.nlm.nih.gov/pubmed/11460962 http://cmuir.cmu.ac.th/handle/6653943832/1948 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Language: | English |
id |
th-cmuir.6653943832-1948 |
---|---|
record_format |
dspace |
spelling |
th-cmuir.6653943832-19482014-08-30T02:00:18Z Therapeutic termination of second trimester pregnancy with vaginal misoprostol Pongsatha S. Tongsong T. Suwannawut O. Objective : To evaluate the efficacy of vaginal misoprostol in therapeutic termination of second trimester pregnancy with a live fetus. Design : Prospective descriptive study. Setting : Maharaj Nakorn Chiang Mai Hospital, Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University. Subjects : Pregnant women meeting the inclusion criteria including 1) pregnancy with a live fetus, 2) gestational age of 14-28 weeks, 3) having an indication for therapeutic termination, 4) Bishop's score of ≤ 4, 5) absence of uterine contraction and leakage of amniotic fluid, 6) no previous classical uterine scar and 7) no contraindication for misoprostol such as hypersensitivity. Intervention : 400 microgram misoprostol gel intravagina every 12 hours. Main outcome measures: Mean induction-delivery time, mean abortion time, maternal side effects. Results: Sixty eight pregnant women were recruited into the study. The mean induction-delivery time was 35.58 ± 34.13 hours, mean abortion time was 35.80 ± 34.13 minutes. Fever was the most common side effect occuring in about two-third of the patients, but no serious maternal complication was observed. Conclusion : 400 microgram vaginal misoprostol is effective for therapeutic termination of second trimester pregnancy with no serious side effects. However, the response to this treatment was markedly varied from patient to patient. 2014-08-30T02:00:18Z 2014-08-30T02:00:18Z 2001 Article 01252208 11460962 JMTHB http://www.scopus.com/inward/record.url?eid=2-s2.0-0034851762&partnerID=40&md5=1fa041b5b747065de8db3aac24c42bed http://www.ncbi.nlm.nih.gov/pubmed/11460962 http://cmuir.cmu.ac.th/handle/6653943832/1948 English |
institution |
Chiang Mai University |
building |
Chiang Mai University Library |
country |
Thailand |
collection |
CMU Intellectual Repository |
language |
English |
description |
Objective : To evaluate the efficacy of vaginal misoprostol in therapeutic termination of second trimester pregnancy with a live fetus. Design : Prospective descriptive study. Setting : Maharaj Nakorn Chiang Mai Hospital, Department of Obstetrics and Gynecology, Faculty of Medicine, Chiang Mai University. Subjects : Pregnant women meeting the inclusion criteria including 1) pregnancy with a live fetus, 2) gestational age of 14-28 weeks, 3) having an indication for therapeutic termination, 4) Bishop's score of ≤ 4, 5) absence of uterine contraction and leakage of amniotic fluid, 6) no previous classical uterine scar and 7) no contraindication for misoprostol such as hypersensitivity. Intervention : 400 microgram misoprostol gel intravagina every 12 hours. Main outcome measures: Mean induction-delivery time, mean abortion time, maternal side effects. Results: Sixty eight pregnant women were recruited into the study. The mean induction-delivery time was 35.58 ± 34.13 hours, mean abortion time was 35.80 ± 34.13 minutes. Fever was the most common side effect occuring in about two-third of the patients, but no serious maternal complication was observed. Conclusion : 400 microgram vaginal misoprostol is effective for therapeutic termination of second trimester pregnancy with no serious side effects. However, the response to this treatment was markedly varied from patient to patient. |
format |
Article |
author |
Pongsatha S. Tongsong T. Suwannawut O. |
spellingShingle |
Pongsatha S. Tongsong T. Suwannawut O. Therapeutic termination of second trimester pregnancy with vaginal misoprostol |
author_facet |
Pongsatha S. Tongsong T. Suwannawut O. |
author_sort |
Pongsatha S. |
title |
Therapeutic termination of second trimester pregnancy with vaginal misoprostol |
title_short |
Therapeutic termination of second trimester pregnancy with vaginal misoprostol |
title_full |
Therapeutic termination of second trimester pregnancy with vaginal misoprostol |
title_fullStr |
Therapeutic termination of second trimester pregnancy with vaginal misoprostol |
title_full_unstemmed |
Therapeutic termination of second trimester pregnancy with vaginal misoprostol |
title_sort |
therapeutic termination of second trimester pregnancy with vaginal misoprostol |
publishDate |
2014 |
url |
http://www.scopus.com/inward/record.url?eid=2-s2.0-0034851762&partnerID=40&md5=1fa041b5b747065de8db3aac24c42bed http://www.ncbi.nlm.nih.gov/pubmed/11460962 http://cmuir.cmu.ac.th/handle/6653943832/1948 |
_version_ |
1681419765814394880 |